PT Diastika Biotekindo TbkISX:CHEK 2 Median PS Value is Rp0.00 as of Jul. 07, 2026. GuruFocus rates ISX:CHEK with a GF Score™ of 2/100. The stock has 1 warning sign investors should review. Among 337 Medical Devices & Instruments companies, PT Diastika Biotekindo Tbk ranks worse than 296735.61% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for PT Diastika Biotekindo Tbk's Median PS Value or its related term are showing as below:
ISX:CHEK's Price-to-Median-PS-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.72 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
PT Diastika Biotekindo Tbk (ISX:CHEK) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
PT Diastika Biotekindo Tbk's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
125.00
/
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Diastika Biotekindo Tbk Median PS Value Related Terms
PT Diastika Biotekindo Tbk Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Diastika Biotekindo Tbk Median PS Value Chart
PT Diastika Biotekindo Tbk Annual Data
Trend
Median PS Value
PT Diastika Biotekindo Tbk Semi-Annual Data
Median PS Value
ISX:CHEK vs ABT, SYK, MDT: Median PS Value Comparison
For the Medical Devices subindustry, PT Diastika Biotekindo Tbk's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Diastika Biotekindo Tbk Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT Diastika Biotekindo Tbk's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where PT Diastika Biotekindo Tbk's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is .
For company reported annually, GuruFocus uses latest annual data as the TTM data. PT Diastika Biotekindo Tbk's Revenue per Share for the trailing twelve months (TTM) ended in . 20 was Rp.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Diastika Biotekindo Tbk (ISX:CHEK) has a Median PS Value of Rp0.00 as of Jul. 07, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on PT Diastika Biotekindo Tbk and its competitors. According to the industry distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 337 companies in the Medical Devices & Instruments industry.
Is PT Diastika Biotekindo Tbk's Median PS Value too high?
PT Diastika Biotekindo Tbk's current Median PS Value is Rp0.00. Based on the distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 337 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PT Diastika Biotekindo Tbk has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does PT Diastika Biotekindo Tbk's Median PS Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PT Diastika Biotekindo Tbk ranks #999999 out of 337 companies for Median PS Value. This places PT Diastika Biotekindo Tbk in the lower half of its industry. The industry median Median PS Value is 0.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.72, based on 337 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on PT Diastika Biotekindo Tbk and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Diastika Biotekindo Tbk's current Median PS Value is Rp0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diastika Biotekindo Tbk stock overvalued right now?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a current Median PS Value of Rp0.00. The current Median PS Value is Rp0.00. PT Diastika Biotekindo Tbk's overall GF Score™ is 2/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For PT Diastika Biotekindo Tbk (ISX:CHEK), the current Median PS Value is Rp0.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressJalan Rawagelam V, Kawasan Industri Pulogadung, Block L, No. Kav 11-13, Gedung Etana Lantai 3, Desa/Kelurahan Jatinegara, Kec. Cakung, Kota Adm. Jakarta Timur, Jakarta, IDN, 13930
PT Diastika Biotekindo Tbk is engaged in providing medical and laboratory equipment solutions in Indonesia. It is engaged in the wholesale trading of laboratory equipment, pharmaceutical products, and medical devices for human use. The company is also involved in wholesale trading of radioactive substances and ionizing radiation generators, and undertakes activities related to the testing and/or calibration of medical devices, as well as the inspection of healthcare facilities and infrastructure. Its product offerings mainly include devices like hematology analyzer, pipette, hemoglobin testing system, etc. The company's operating segments are: Diagnostics Group, which generates the maximum revenue, and Life Sciences Group. Geographically, all of its revenue is derived from Indonesia.
2GF Score
Get the complete analysis for ISX:CHEK
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:CHEK has been successfully added to your 